glp 1 landscape Market Overview: GLP-1 Agonists and the Obesity Market | Blog GLP-1 Agonists Market Exclusive Research

Back US FDA (Dec 2017) 'Drug Trial Snapshot: Ozempic'

Triglyceride content was measured using Infinity Triglycerides reagent (Thermo Fisher Scientific, #TR22421) according to the manufacturers instructions and normalized to wet tissue weight

Side Effect Profile Comparison The side effect profile of compounded GLP-1 medications is generally expected to be similar to brand-name versions because the side effects are driven primarily by the active ingredients mechanism of action, not by formulation-specific factors

In March 2024, the FDA approved semaglutide (Wegovy) not just for weight loss but also to reduce cardiovascular risk in adults with known heart disease

10.1038/nrm.2017.95 29 HeynJ.HeuschkelM

Unauthorized or counterfeit injectable products carry even more risks, such as infections due to lack of sterility, allergic reactions and other serious negative outcomes due to contamination, improper handling or unsafe administration, Health Canada said